Daniel Richardson, MD

Fellow, Division of Hematology & Oncology

Education

Undergraduate: Ohio University
Medical School:
The Ohio State University College of Medicine
Residency:
The Ohio State University Wexner Medical Center

Research & Career Path

  • Clinical: Hematologic malignancy with a primary focus on leukemia.
  • Research: Health Services Research in improving quality of care for cancer patients. Research interests include utilizing novel technology to mitigate unmet needs in cancer care, patient decision making in newly diagnosed leukemia, financial toxicity, and financial conflicts of interest.

Awards/Grants

  • AHRQ Cecil G. Sheps Center for Health Services Research Post-Doctoral Research T32 Training Grant Recipient (2018-2019)

Publications

Richardson DR, Devine SM, Nash R. “A Challenge to Discriminating Psychosocial Eligibility Criteria: Exploring the ethical justification for excluding patients with psychosocial risk factors from hematopoietic cell transplantation,” Bone Marrow Transplantation. Accepted for publication. (2018).

Richardson DR, Huang Y, McGinty HL, Elder P, Newlin J, Kirkendall C, Andritsos L, Benson D, Blum W, Efebera Y, Penza S, Hofmeister C, Jaglowski S, Klisovic R, Vasu S, William B, Devine SM, Rosko AE. “Psychosocial Risk Predicts High Readmission Rates for Hematopoietic Cell Transplant Recipients,” Bone Marrow Transplantation, Epub ahead of print, doi: 10.1038/s41409-018-0118-4, (2018)

Richardson DR, Riches M, Lazarus H. “Prophylaxis and treatment of invasive fungal infections in neutropenic cancer and hematopoietic stem cell transplant patients.” Forthcoming in: Ghannoum MA, Perfect JR (ed). Antifungal Therapy. Informa Healthcare. (2018).

Meetings: Abstracts presented

ASH